Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 46 rue Henri Huchard, Paris, France.
J Heart Lung Transplant. 2010 Nov;29(11):1270-6. doi: 10.1016/j.healun.2010.05.010. Epub 2010 Jul 1.
The impact of previous cardiovascular disease on the outcome of lung transplantation may be important but remains unstudied.
Cardiovascular risk factors, echocardiography, right heart catheterization, isotopic ventriculography and vascular ultrasonography data were obtained from 258 adults who underwent lung transplantation at our center between 1988 and 2007. The effect of these parameters on survival and cardiovascular disease after transplantation was determined using the Cox model.
By multivariate analysis, diabetes (hazard ratio [HR]: 2.4), atrial fibrillation (HR: 3.51), elevated systolic pulmonary artery pressure (HR: 1.23 per 10 mm Hg) and low cardiac index (HR: 1.47 per-liters/min/m(2)) before transplantation were associated with a higher risk of death after transplantation. Heart failure (2.08 cases per 100 patient-years) and atherothrombosis (2.5 cases per 100 patient-years) were frequent after lung transplantation. A history of atherothrombosis (HR: 12.98) and diabetes (HR: 5.8) before transplantation were associated with a higher risk of atherothrombosis after transplantation. Major cardiovascular events led to death in 11 patients. Diabetes (HR: 62.5) and a low cardiac index (HR: 6.8 per-liters/min/m(2)) were associated with a higher risk of death from cardiovascular causes.
Diabetes and a history of atrial fibrillation before lung transplantation were associated with excess mortality after transplantation. Diabetes was also associated with a major increase in the risk of atherothrombosis and death from cardiovascular causes. Lung transplant recipients may be considered at high risk for cardiovascular disease.
既往心血管疾病对肺移植结局的影响可能很重要,但仍未得到研究。
我们从 1988 年至 2007 年在中心接受肺移植的 258 名成人中获得了心血管危险因素、超声心动图、右心导管检查、同位素心室造影和血管超声检查数据。使用 Cox 模型确定这些参数对移植后生存和心血管疾病的影响。
通过多变量分析,糖尿病(风险比 [HR]:2.4)、心房颤动(HR:3.51)、术前肺动脉收缩压升高(每 10mmHg HR:1.23)和低心指数(每升/分钟/平方米 HR:1.47)与移植后死亡风险增加相关。心力衰竭(每 100 患者年 2.08 例)和动脉粥样硬化血栓形成(每 100 患者年 2.5 例)在肺移植后很常见。移植前动脉粥样硬化血栓形成史(HR:12.98)和糖尿病(HR:5.8)与移植后动脉粥样硬化血栓形成风险增加相关。主要心血管事件导致 11 名患者死亡。糖尿病(HR:62.5)和低心指数(HR:每升/分钟/平方米 6.8)与心血管原因死亡风险增加相关。
肺移植前糖尿病和心房颤动病史与移植后死亡率增加有关。糖尿病还与动脉粥样硬化血栓形成和心血管原因死亡的风险显著增加有关。肺移植受者可能被认为存在心血管疾病的高风险。